Pharmafile Logo
Pharmafocus logo
Advanced Search
national-cancer-institute-kmvohcb-w5g-unsplash_1

FDA approves Pfizer’s HRR mCRPC drug

June 21, 2023
Medical Communications FDA, Oncology, Pfizer, breast cancer, oncology, prostate cancer

US-based pharmaceutical and biotechnology company Pfizer has announced that the US Food and Drug Administration (FDA) has approved its homologous …

News

PharmaTher and Vitruvias sign collaboration agreement to commercialise ketamine-based treatment in the US

June 21, 2023
Medical Communications Ketamine, Neurology, PharmaTher, Vitruvias, commercialisation

Specialty pharmaceutical companies, Canadian PharmaTher and US-based Vitruvias, have entered into a commercialisation partnership to bring Ketarx products to the …

News

Sirnaomics advances isSCC candidate into late-stage clinical development

June 20, 2023
Research and Development FDA, Oncology, Sirnaomics, clinical trial, isSCC

Global RNA therapeutics biopharmaceutical company Sirnaomics has announced that it has advanced its Squamous Cell Carcinoma in situ (isSCC) candidate …

News

Abu Dhabi’s Department of Health, M42 and AbbVie enter strategic partnership

June 20, 2023
Medical Communications AbbVie, Abu Dhabi, DoH, M42, Oncology, strategic partnership

Abu Dhabi’s Department of Health (DoH) has signed a Memorandum of Understanding (MoU) with AbbVie and M42 to advance research …

News

GSK announces extension of FDA’s review for momelotinib

June 20, 2023
Medical Communications FDA, GSK, Oncology, momelotinib, new drug application

GSK has announced that the US Food and Drug Administration (FDA) has extended its review period for the new drug …

News

Santhera and Catalyst Pharmaceuticals sign $231m license and collaboration deal

June 20, 2023
Medical Communications Catalyst Pharmaceuticals, Rare Diseases, Vamorolone, licence and collaboration, santhera

Swiss specialty pharmaceutical company Santhera and US-based biopharmaceutical company Catalyst Pharmaceuticals have announced that they have signed an exclusive license …

News

Immodulon appoints Josefine Roemmler-Zehrer as chief medical officer

June 20, 2023
Immodulon, Josefine Roemmler-Zehrer, appointment, chief medical officer

Cancer immunotherapy company Immodulon has announced that it has appointed Josefine Roemmler-Zehrer as chief medical officer, bringing with her vast …

Appointment

Scientists develop 3D printed pills for time-controlled release

June 19, 2023
Research and Development 3d printed pills, 3d printing, Max Planck Insititute, Pharmacy, University of California

A team of scientists at the Max Planck Institute (MPI) for Informatics, Germany, and the University of California, US, have …

News

Vaxxas opens manufacturing facility for needle-free vaccine patch

June 19, 2023
Research and Development Immunology, Vaxxas, manufacturing, needle-free vaccines, vaccines

Clinical stage biotech company Vaxxas has announced that it is opening a biomedical manufacturing facility in Brisbane, Australia, for the …

News

ImmuPharma initiates phase 2/3 clinical trial for lupus treatment

June 19, 2023
Research and Development Avion Pharmaceuticals, ImmuPharma, Immunology, Lupus, clinical trial

ImmuPharma has announced that it will commence a phase 2/3 adaptive clinical trial of P140 (Lupuzor) in patients with systemic …

News

Rani Therapeutics’ oral ‘robotic pill’ delivers injection trans-enterically

June 19, 2023
Medical Communications Osteoporosis, Rani Therapeutics, injection, osteoporosis, robotic pill, robotics

US Rani Therapeutics, a clinical-stage biotherapeutics company, has reported new results from its phase 1 trial into the RaniPill capsule …

News

LEO Pharma appoints Leanne Walsh as general manager and vice president for UK and Ireland

June 19, 2023
LEO Pharma, appointment, general manager, vice president

Medical dermatology company LEO Pharma has announced that it has appointed Leanne Walsh as its new general manager and vice …

Appointment
document-428331_960_720

Nordic Bioscience receives FDA Letter of Support for biomarker in aggressive tumour fibrosis

June 16, 2023
Research and Development FDA, Nordic Bioscience, Oncology, Roche, tumour fibrosis

Danish biomarker company Nordic Bioscience has announced that the US Food and Drug Administration (FDA) has awarded it a Letter …

News

Takeda and HUTCHMED’s cancer drug shown to prolong overall survival

June 16, 2023
Research and Development HUTCHMED, Oncology, Takeda, colorectal cancer

Clinical trial data from a study into the metastatic colorectal cancer (CRC) drug fruquintinib, which is being developed by Japanese …

News
Antibiotics image

FDA gives Eagle Pharmaceuticals Qualified Infectious Disease Product (QIDP) and Fast-Track Designation for SCABP drug

June 15, 2023
Research and Development Eagle Pharmaceuticals, FDA, FDA fast-track, Immunology, SCABP

US-based pharmaceutical company Eagle Pharmaceuticals has announced that the US Food and Drug Administration (FDA) has granted its severe community-acquired …

News
shaking-hands-gb7ac17374_1920

Astellas and Cullgen enter into $1.9bn strategic collaboration to progress protein degraders

June 15, 2023
Research and Development Astellas, Cullgen, Oncology, protein degraders

Japanese pharmaceutical company Astellas and US-based clinical-stage biopharmaceutical company Cullgen have announced that they have entered into a strategic research …

News

Critical Path Institute receives FDA Biomarker LOS for DIPI biomarkers

June 14, 2023
Research and Development Critical Path Institute, Endocrinology, FDA, biomarkers, pancreatic injury

US-based Critical Path Institute (C-Path) has announced that the Biomarker Qualification Program (BQP) at the Center for Drug Evaluation and …

News
clinical_trials

Kymera Therapeutics reports positive data in cancer drug trials

June 14, 2023
Research and Development Cancer, Kymera Therapeutics, Oncology, autoimmune diseases, clinical trials, inflammatory diseases

US clinical-stage biopharmaceutical company Kymera Therapeutics has shared new data regarding its oncology programmes KT-333 and KT-413, highlighting their robust dose-dependent …

News
cancer_cells_from_the_breast_cancer_now_tissue_bank_cell_programme

AstraZeneca’s breast cancer drug given Priority Review by FDA

June 13, 2023
Business Services AstraZeneca, FDA, Oncology, breast cancer

UK-based pharmaceutical company AstraZeneca has announced that the US Food and Drug Administration (FDA) has accepted its New Drug Application …

News

Novo Nordisk invests DKK 15.9bn to expand API production in Denmark

June 13, 2023
Manufacturing and Production APIs, Chronic Diseases, Novo Nordisk, chronic diseases

Danish healthcare company Novo Nordisk has announced that it will invest another DKK 15.9bn into expanding an existing Active Pharmaceutical …

News
The Gateway to Local Adoption Series

Latest content

STADA and Bio-Thera’s Gotenfia receives positive CHMP opinion for autoimmune diseases

December 18, 2025

Norgine enters exclusive licensing agreement with Vir Biotechnology

December 18, 2025

Incyclix appoints Kimberly Blackwell to Board of Directors

December 17, 2025

Hansa Biopharma appoints Max Sakajja as Vice President, General Manager Europe and International

December 17, 2025

GSK’s Exdensur receives MHRA approval for asthma and rhinosinusitis

December 16, 2025